sorafenib has been researched along with Carotid Stenosis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Huang, C; Zhang, W; Zhu, Y | 1 |
1 other study(ies) available for sorafenib and Carotid Stenosis
Article | Year |
---|---|
Drug-eluting stent specifically designed to target vascular smooth muscle cell phenotypic modulation attenuated restenosis through the YAP pathway.
Topics: Animals; Aorta; Apoptosis Regulatory Proteins; Cardiovascular Agents; Carotid Arteries; Carotid Stenosis; Cell Proliferation; Cells, Cultured; Drug-Eluting Stents; Male; Models, Animal; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Nuclear Proteins; Phenotype; Prosthesis Design; Prosthesis Implantation; Rabbits; Rats; Serum Response Factor; Signal Transduction; Sorafenib; Trans-Activators; YAP-Signaling Proteins | 2019 |